Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma
Identifying High-Risk Patients Pre-existing conditions that may increase NAION risk with GLP-1 use include: Diabetes, especially long-standing or poorly controlled Hypertension Hyperlipidemia Sleep apnea History of previous NAION in one eye Age is a significant factor, with individuals over 50 at higher risk
Melanocortins in research: complete guide to Melanotan II, PT-141 bremelanotide, afamelanotide and MC1R-MC5R receptors The melanocortin system is a central and peripheral neuroendocrine network formed by five G protein-coupled receptors (MC1R through MC5R), their endogenous ligands derived from proopiomelanocortin (POMC) alpha-MSH, beta-MSH, gamma-MSH, ACTH and their natural antagonists agouti (ASIP) and AgRP
doi: 10.3389/fphar.2025.1529194 47
While this specific combination hasn't been studied in controlled trials, BPC-157's documented gastroprotective and anti-ulcer effects in animal models provide a mechanistic rationale for its use alongside medications that can irritate the GI tract